Apply Now - Doctoral Candidate 14 - Dresden University of Technology, Germany

This project and DC14 will develop hydrogel-based formulations loaded with bacteriophages to treat peri-implant mucositis and peri-implantitis. The project focuses on establishing in vitro biofilm models on titanium surfaces, identifying effective phages, exploring synergistic effects with antibiotics, and designing injectable composites with bioactive glass. This research aims to enhance biofilm removal and improve clinical outcomes for implant-related infections. 

Learn more about this position at EURAXESS 

• More information at SHIELD's web page about Research Project 14

APPLY HERE: Dresden University of Technology, Germany - Application Deadline: 24 Nov 2025 - 23:59:59   Time zone:  Berlin/Germany

Research activities include:

• Development and characterization of injectable, phage-loaded biomaterials based on (bio)polymers and bioactive glasses.
• Isolation, maintenance, and antibacterial testing of bacteriophages against oral bacterial species.
• Analysis of phage activity—both free and embedded in biomaterials—using in vitro biofilm models.

Training and mobility:

• Research secondments at SHIELD partner institutions:
  • University Hospital Regensburg (Germany)
  • University of Oslo (Norway)
  • Industrial partner (tbd)

Participation in specialised training workshops and international conferences.

This PhD position is part of the European Doctoral Network “SHIELD” (Strategies for Healing Implant-associated infections and Enhancing Longevity in Devices), led by the University of Gothenburg. 

SHIELD offers an exciting opportunity for 16 early-career researchers to contribute to transforming the management of infections associated with medical implants. Focused on addressing the challenges posed by implant-associated infections (IAIs), SHIELD aims to deepen our understanding of IAI mechanisms and develop innovative antibacterial biomaterials to improve patient outcomes.